Baxter International Inc.
General ticker "BAX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $14.7B (TTM average)
Baxter International Inc. does not follow the US Stock Market performance with the rate: -19.7%.
Estimated limits based on current volatility of 1.0%: low 18.65$, high 19.08$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-08-29, amount 0.17$ (Y3.68%)
- Total employees count: 38000 (-36.7%) as of 2024
- US accounted for 0.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Liquidity and credit risks, Strategic risks and growth management, Manufacturing disruptions, Cybersecurity threats, Reputation and brand risks
- Current price 18.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [22.67$, 36.47$]
- 2025-12-31 to 2026-12-31 estimated range: [22.62$, 36.28$]
Financial Metrics affecting the BAX estimates:
- Positive: with PPE of 10.7 at the end of fiscal year the price was neutral
- Positive: -3.60 < Operating profit margin, % of 0.13
- Positive: -4.48 < Investing cash flow per share per price, % of -4.22
- Positive: 6.82 < Operating cash flow per share per price, % of 6.87
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 18.93 < Shareholder equity ratio, % of 27.01 <= 41.86
- Positive: Inventory ratio change, % of 0.54 <= 0.84
Short-term BAX quotes
Long-term BAX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $10,022.00MM | $10,388.00MM | $10,648.00MM |
| Operating Expenses | $12,867.00MM | $9,681.00MM | $10,634.00MM |
| Operating Income | $-2,845.00MM | $707.00MM | $14.00MM |
| Non-Operating Income | $-403.00MM | $-465.00MM | $-303.00MM |
| Interest Expense | $394.00MM | $439.00MM | $341.00MM |
| R&D Expense | $450.00MM | $518.00MM | $590.00MM |
| Income(Loss) | $-3,248.00MM | $242.00MM | $-289.00MM |
| Taxes | $-135.00MM | $61.00MM | $37.00MM |
| Other Income(Loss) | $692.00MM | $2,482.00MM | $-312.00MM |
| Profit(Loss)* | $-2,433.00MM | $2,656.00MM | $-649.00MM |
| Stockholders Equity | $5,833.00MM | $8,402.00MM | $6,964.00MM |
| Inventory | $2,679.00MM | $1,918.00MM | $2,046.00MM |
| Assets | $28,287.00MM | $28,276.00MM | $25,782.00MM |
| Operating Cash Flow | $1,211.00MM | $1,726.00MM | $1,019.00MM |
| Capital expenditure | $635.00MM | $436.00MM | $460.00MM |
| Investing Cash Flow | $-931.00MM | $3,213.00MM | $-626.00MM |
| Financing Cash Flow | $-1,438.00MM | $-3,489.00MM | $-1,081.00MM |
| Earnings Per Share** | $-4.83 | $5.25 | $-1.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.